Terns Pharmaceuticals Inc (TERN)
5.79
+0.08
(+1.40%)
USD |
NASDAQ |
Nov 22, 16:00
5.79
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Cash from Operations (Quarterly): -16.46M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -16.46M |
| June 30, 2024 | -16.18M |
| March 31, 2024 | -22.80M |
| December 31, 2023 | -19.32M |
| September 30, 2023 | -20.70M |
| June 30, 2023 | -12.99M |
| March 31, 2023 | -14.38M |
| December 31, 2022 | -11.21M |
| September 30, 2022 | -13.44M |
| June 30, 2022 | -11.16M |
| Date | Value |
|---|---|
| March 31, 2022 | -13.30M |
| December 31, 2021 | -10.67M |
| September 30, 2021 | -8.082M |
| June 30, 2021 | -8.76M |
| March 31, 2021 | -14.32M |
| December 31, 2020 | -7.387M |
| September 30, 2020 | -6.313M |
| June 30, 2020 | -8.822M |
| March 31, 2020 | -7.287M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-22.80M
Minimum
Mar 2024
-6.313M
Maximum
Sep 2020
-12.82M
Average
-12.99M
Median
Jun 2023
Cash from Operations (Quarterly) Benchmarks
| Eli Lilly and Co | 3.712B |
| Viking Therapeutics Inc | -21.96M |
| Biomarin Pharmaceutical Inc | 221.48M |
| Elite Pharmaceuticals Inc | 1.457M |
| Verrica Pharmaceuticals Inc | -8.558M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 31.75M |
| Cash from Financing (Quarterly) | 163.29M |
| Free Cash Flow | -74.83M |
| Free Cash Flow Per Share (Quarterly) | -0.2115 |
| Free Cash Flow Yield | -17.29% |